 |
 |
Excellent news! This time you will have the HELP! If anybody want to receive this scientific paper, only ask for it to me Regards for everybody Elizabeth Argentina First part http://www.unmc.edu/News/GENDPARK2004.HTM UNMC, Columbia scientists report therapeutic vaccine approach for Parkinson’s disease Scientists at the University of Nebraska Medical Center (UNMC) in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson’s disease. The findings appear today (June 14) in the Proceedings of the National Academy of Sciences (PNAS) of the United States of America. PNAS is among the world’s most-cited multidisciplinary scientific journals. The report, titled “Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson’s disease,” appears online today. A print copy will be released June 22. “It’s a significant conceptual advance for Parkinson’s disease therapy,” said Howard Gendelman, M.D., David T. Purtilo Distinguished Chair of Pathology and Microbiology at UNMC and director of the Center for Neurovirology and Neurodegenerative Disorders (CNND) where the research was conducted. “As of today drugs are available which only treat symptoms of disease. Regrettably, nothing is now available that prevents or reverses the course of brain degeneration. Our vaccine approach changes this by bringing a new excitement to a developing field of investigation called neuroprotective medicine. A vaccine therapy that protects the dopamine nerve cells damaged in Parkinson’s disease is novel.” “The research is very exciting,” said Serge Przedborski, M.D., Ph.D., professor of neurology and pathology in the Center for Neurobiology and Behavior at Columbia University and a world-renowned expert in Parkinson's disease research. “Using this approach, the harmful aspects of inflammation associated with Parkinson’s disease could be eliminated.” The discovery, however, is just the beginning, Dr. Gendelman said. More research is being done at UNMC to improve this approach. Some aspects include finding the types of immune cells responsible for the protection, as well as developing diagnostic techniques like enhanced magnetic resonance imaging to track disease progression. Clinical trials in humans are being developed at Columbia University. ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn